Screening Mammography — A Long Run for a Short Slide?
- 23 September 2010
- journal article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 363 (13) , 1276-1278
- https://doi.org/10.1056/nejme1008369
Abstract
No screening test has ever been more carefully studied than screening mammography. In the past 50 years, more than 600,000 women have participated in 10 randomized trials, each involving approximately 10 years of follow-up. Given this extraordinary research effort, it is ironic that screening mammography continues to be one of the most contentious issues within the medical community.The juxtaposition of such a charged medical debate in the face of such an exhaustive scientific investigation is in itself instructive. For context, one trial involving fewer than 150 men who were followed for less than 2 years was sufficient to convince . . .Keywords
This publication has 8 references indexed in Scilit:
- Effect of Screening Mammography on Breast-Cancer Mortality in NorwayNew England Journal of Medicine, 2010
- Why did the breast cancer lymph node status distribution improve in Denmark in the pre-mammography screening period of 1978–1994?Acta Oncologica, 2010
- Effects of Mammography Screening Under Different Screening Schedules: Model Estimates of Potential Benefits and HarmsAnnals of Internal Medicine, 2009
- Rate of over-diagnosis of breast cancer 15 years after end of Malmö mammographic screening trial: follow-up studyBMJ, 2006
- Content of invitations for publicly funded screening mammographyBMJ, 2006
- Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trialsThe Lancet, 2005
- Ten-Year Risk of False Positive Screening Mammograms and Clinical Breast ExaminationsNew England Journal of Medicine, 1998
- Effects of treatment on morbidity in hypertension. Results in patients with diastolic blood pressures averaging 115 through 129 mm HgJAMA, 1967